Muscarinic Receptor PET in Neurodegeneration: Promise, Pitfalls, and Translational Priorities. [PDF]
Filippi L, Danieli R.
europepmc +1 more source
Translational PBPK Modeling and Exposure‐Response Analysis of AT‐RvD1 for Treating Sjögren's Disease
ABSTRACT Sjögren's disease (SD) is an autoimmune condition characterized by chronic inflammation and impaired secretory function of the salivary glands (SG). The proresolving lipid mediator AT‐RvD1 restores SG function in SD‐like mice; however, its tissue pharmacokinetics, exposure‐response relationships, and human dose predictions remain poorly ...
Venkata K. Yellepeddi +3 more
wiley +1 more source
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies
COPD is a heterogeneous disease driven by overlapping neutrophilic and eosinophilic inflammatory pathways. This review highlights the shift from symptom‐based treatment toward phenotype‐ and biomarker‐directed care. Blood eosinophils, FeNO, and IgE predict corticosteroid responsiveness and identify candidates for biologic therapy.
Sasha Raman +3 more
wiley +1 more source
Role of Muscarinic Receptor Signaling Processes in Specific Aspects of Morphine-Induced Respiratory Depression in Rats. [PDF]
Getsy PM +7 more
europepmc +1 more source
Enhanced mucosal contractile activity following rapid, reversible inhibition of bladder activity by dimethyl sulfoxide (DMSO). [PDF]
Katugampola L +5 more
europepmc +1 more source
Nonlinear heart rate variability differed by age and sex in typically developing youth. Nonlinear measures were associated with parasympathetic indices. Figure generated in Biorender. Abstract Linear heart rate variability (HRV) quantifies heart rate (HR) changes due to stochastic processes while nonlinear HRV captures the complexity of the HR ...
Alexs A. Matias +4 more
wiley +1 more source
Toward a Pluralistic Model for the Schizophrenia Spectrum-Dopamine and Beyond. [PDF]
Keshavan MS +11 more
europepmc +1 more source
Abstract Exogenous glucagon‐like peptide 2 (GLP‐2) administration increases small intestinal growth and mesenteric blood flow, although the vascular mechanisms involved remain unclear. The objective of this study was to characterize the effects of exogenous GLP‐2 administration on glucagon‐like peptide 2 (GLP‐2)‐, vasoactive intestinal peptide (VIP ...
Gabriel S. S. David +3 more
wiley +1 more source
Emerging non-D<sub>2</sub> receptor-based therapies for schizophrenia: a focus on muscarinic and glutamatergic pathways. [PDF]
Wang Y, Wang J, Zhang X, Liu X.
europepmc +1 more source

